Blog

Pathologic response to neoadjuvant chemotherapy in HPV-associated oropharynx cancer Sadeghi N, Khalife S, Mascarella MA, Ramanakumar AV, Richardson K, Joshi AS, Bouganim N, Taheri R, Fuson A, Siegel R. From Head and Neck, March 2020;42(3):417-425. Article Review by Joe Goodman, MD Background / Hypothesis According to the authors, a paradigm shift is underway leading to de-escalation trials for HPV-associated oropharynx cancer (OPC). Because of the excellent …

In light of the recent concerns about COVID-19 and the growing number of travel bans placed on both international and domestic colleagues, the AHNS Leadership has elected to postpone the AHNS 10th International Conference until July 22nd-25th 2021. This decision was made to preserve the health and safety of our attendees and patients. Abstract Submissions …

How COVID-19 is Affecting our Head and Neck Community: AHNS COVID-19 Bulletin By the AHNS Leadership and Patient Care Division The American Head and Neck Society (AHNS) wishes to recognize and laude the actions of membership in the face of the COVID-19 pandemic. While abiding by our mission, “Advance Education, Research and Quality of Care …